d-alpha tocopherol has been researched along with Basal Ganglia Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischot, L; Porsius, AJ; Van den Brink, G | 1 |
| Eranti, VS; Gangadhar, BN; Janakiramaiah, N | 1 |
| Banay-Schwartz, M; Cohen, CG; Deutsch, SI; Leighton, M; Rosse, RB; Scarcella, E; Theut, SK | 1 |
1 review(s) available for d-alpha tocopherol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Vitamin E in extrapyramidal disorders.
Topics: Basal Ganglia Diseases; Humans; Vitamin E | 1993 |
1 trial(s) available for d-alpha tocopherol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Haloperidol-induced extrapyramidal reaction: lack of protective effect by vitamin E.
Topics: Adolescent; Adult; Antioxidants; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Haloperidol; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Time Factors; Vitamin E | 1998 |
1 other study(ies) available for d-alpha tocopherol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Basal Ganglia Diseases; Benztropine; Chronic Disease; Cognition; Drug Therapy, Combination; Glycine; Haloperidol; Humans; Loxapine; Male; Pilot Projects; Schizophrenia; Thiothixene; Vitamin E | 1989 |